Showing 491 - 500 of 557 for "Kim & Chang" with applied filters
21 August 2017 by
Practitioners have welcomed Intellectual Property Office of Singapore (IPOS) amendments to the patent regime to spur innovation and improve the quality of patents granted there.
17 August 2017 by
Bénédicte Nolens, senior director and head of risk and strategy, at Hong Kong’s Securities and Futures Commission (SFC), talks to Karry Lai of Asialaw about her experience working in compliance, her recent focus on fintech, and her observations about career progression for women, including women as board directors.
09 August 2017 by
Indonesia has drafted a new competition law that contains heavier fines for businesses convicted of competition, more enforcement power for the competition authority and the introduction of a leniency programme. While the regulator has been struggling to get the law to parliament for a number of years, it is now thought to have enough support to be to be passed later this year.
08 August 2017 by
Latest moves and updates from Hong Kong, India and Singapore
07 August 2017 by
Japan has launched significant new corporate governance reform by revising its Stewardship Code, which requires institutional investors to disclose voting records for investments and establish governance structures to prevent conflicts of interest. The challenges will be in how the changes are implemented ahead, including how existing legislation might conflict with the controversial subject of collective engagement between investors and the companies they invest in.
02 August 2017 by
From the Taj Mahal Palace Hotel to the Nokia ringtone and the stripes of 7-Eleven convenience stores, Karry Lai explains why non-traditional trade mark innovation in Asia is more than meets the eye
01 August 2017 by
Laos amends investment law to attract business in targeted sectors
27 July 2017 by
The China Food and Drug Administration (CFDA) is planning to introduce a patent linkage scheme that will require a generic applicant to make a non-infringement declaration against an innovator’s patent portfolio. By creating this linkage, innovators can rest assured that their innovations are protected while generic drug companies are motivated to get regulatory approval for entry into market by proving that a patent is invalid or not infringed. However, observers warn of potential challenges in implementation.
26 July 2017 by
This year marks the fifth year of President Xi’s anti-corruption campaign, but China is moving only slowly up the ranks of the least corrupt jurisdictions globally. Transparency International had it at 79 on its corruption perception index in 2016, compared to 83 the year before. At the same time, proposals to amend the anti-unfair competition law, a social credit system and a national supervisory commission that is expected be in place by March 2018 shows a clear message from the Chinese government: Big Brother is watching and investigations into suspected corruption will only intensify, so businesses operating in China should ready themselves for legal consequences if their anti-corruption policies are weak.
05 July 2017 by
The research for this year’s Asialaw Asia-Pacific Dispute Resolution Awards 2017 is complete and the shortlists will be available on this page soon.